Jaguar Health, Inc. filed a Form D with the Securities and Exchange Commission on 2025-09-23.
Jaguar Health, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 23, 2025. Jaguar Health, Inc. trades on Nasdaq as JAGX; it was formerly Jaguar Animal Health, Inc. The filing reports $2.38M sold. Its industry group is Pharmaceuticals. It names Lisa Conte (Executive Officer, Director), Carol Lizak (Executive Officer), Steven King (Executive Officer) (SEC Form D, September 23, 2025).
Is this your company?
Sell to companies like Jaguar Health, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-09-23 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Jaguar Health, Inc.
Free to see. No signup.
More on the people and the money behind Jaguar Health, Inc., from the filings we hold.
Pharmaceuticals raises by companies based in California, filed within 90 days of this one, largest first.
Get an email when Jaguar Health, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Jaguar Health, Inc. raises, hires or launches. No email unless you switch it on.
Watch Jaguar Health, Inc. →Get the full cited report on Jaguar Health, Inc.
What the filing shows about Jaguar Health, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Jaguar Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Jaguar Health, Inc.'s address as 200 Pine St., Ste 400, San Francisco, CA 94104.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Jaguar Health, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Jaguar Health, Inc. is a registered filer with the SEC (CIK 1585608) and has filed since 2023-05-11. 9 filings are on record, the latest on 2026-07-01.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Jaguar Health, Inc.'s Form D of 2025-09-23 names Lisa Conte, Carol Lizak, Steven King and 6 more as its officers, directors or promoters.
Its new offerings report $62.24M sold across 9 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Lisa Conte is named as Executive Officer and Director on the Form D that Jaguar Health, Inc. filed with the SEC on 23 September 2025, one of 9 people that filing names.
Carol Lizak is named as Executive Officer on the Form D that Jaguar Health, Inc. filed with the SEC on 23 September 2025, one of 9 people that filing names.
Steven King is named as Executive Officer on the Form D that Jaguar Health, Inc. filed with the SEC on 23 September 2025, one of 9 people that filing names.
Jonathan Wolin is named as Executive Officer on the Form D that Jaguar Health, Inc. filed with the SEC on 23 September 2025, one of 9 people that filing names.
James Bochnowski is named as Director on the Form D that Jaguar Health, Inc. filed with the SEC on 23 September 2025, one of 9 people that filing names.
John Micek III is named as Director on the Form D that Jaguar Health, Inc. filed with the SEC on 23 September 2025, one of 9 people that filing names.
Anula Jayasuriya is named as Director on the Form D that Jaguar Health, Inc. filed with the SEC on 23 September 2025, one of 9 people that filing names.
Jonathan Siegel is named as Director on the Form D that Jaguar Health, Inc. filed with the SEC on 23 September 2025, one of 9 people that filing names.
Pravin Chaturvedi is named as Executive Officer on the Form D that Jaguar Health, Inc. filed with the SEC on 23 September 2025, one of 9 people that filing names.
9 people named on the filing — 5 holding an executive role and 4 as directors only.
Named as of the 2025-09-23 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Jaguar Health, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Jaguar Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Jaguar Health, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Jaguar Health, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Jaguar Health, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Jaguar Health, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/jaguar-health-inc-form-d-25000003